Retatrutide is an investigational peptide that acts as a triple agonist of the glucose-dependent insulinotropic polypeptide (GIP) receptor, the glucagon-like peptide-1 (GLP-1) receptor, and the glucagon receptor. This synergistic mechanism is being extensively researched for its profound impact on metabolic regulation, thermogenesis, and lipolysis.
Produced by Pyramid Labs under strict quality control protocols, this product ensures laboratory researchers receive a consistent, high-potency compound. The lyophilized format allows for long-term storage when kept in controlled refrigeration (2-8°C).
Reviews
There are no reviews yet.